AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
By: Mary Norine Walsh, Lars Køber, Karen Hahnle-Sliwa, Marianna Adamo, Anubha Agarwal, Amitava Banerjee, Biykem Bozkurt, Maja Cikes, Albertino Damasceno, Akshay Desai, G. Michael Felker, Gail Hogan, Koichiro Kinugawa, Michelle Kittleson, Carolyn Lam, Theresa McDonagh, Marco Metra, Wilfried Mullens, Antonio Ribeiro, Yolanda Vaughn, Amanda Vest and the Heart Failure Association (HFA) of the European Society of Cardiology on behalf of the Joint American Heart Association (AHA)/American College of Cardiology (ACC)/European Society of Cardiology (ESC)/ World Heart Federation (WHF) Task Force for the Universal Definition of Heart Failure in collaboration with the Heart Failure Society of America (HFSA)
References
- Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, Anker SD, Atherton J, Bohm M, Butler J, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021;27:387–413. DOI: 10.1002/ejhf.2115
- Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, Fonarow GC, Heidenreich P, Ho JE, Hsich E, et al. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail. 2023;29:1412–1451. DOI: 10.1016/j.cardfail.2023.07.006
- Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure–associated hospitalizations in the United States. J Am Coll Cardiol. 2013;61:1259–1267. DOI: 10.1016/j.jacc.2012.12.038
- Khan SS, Berwanger O, Fiuzat M, McMurray JJV, Narula J, Prabhakaran D, Sliwa K, Tromp J, Vaduganathan M. Prioritising the primary prevention of heart failure. Lancet. 2025;406:1138–1153. DOI: 10.1016/S0140-6736(25)01393-5
- Palaniappan LP, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Currie ME, Earlie RS, et al. 2026 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2026;153:e275–e906. DOI: 10.1161/CIR.0000000000001412
- Piña IL, Jimenez S, Lewis EF, Morris AA, Onwuanyi A, Tam E, Ventura HO. Race and ethnicity in heart failure. J Am Coll Cardiol. 2021;78:2589–2598. DOI: 10.1016/j.jacc.2021.06.058
- Tromp J, Ouwerkerk W, Teng T-HK, Cleland JGF, Bamadhaj S, Angermann CE, Dahlstrom U, Tay WT, Dickstein K, Ertl G, et al. Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. Eur Heart J. 2022;43:2224–2234. DOI: 10.1093/eurheartj/ehac103
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; the Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018) [published correction appears in Circulation. 2024;149:e1164]. Circulation. 2018;138:
e652 . DOI: 10.1161/CIR.0000000000000617 - McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et al; ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–3726. DOI: 10.1093/eurheartj/ehab368
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895–e1032. DOI: 10.1161/CIR.0000000000001063
- Anjan VY, Loftus TM, Burke MA, Akhter N, Fonarow GC, Gheorghiade M, Shah SJ. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol. 2012;110:870–876. DOI: 10.1016/j.amjcard.2012.05.014
- Verbrugge FH, Omote K, Reddy YNV, Sorimachi H, Obokata M, Borlaug BA. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality. Eur Heart J. 2022;43:1941–1951. DOI: 10.1093/eurheartj/ehab911
- Poppe KK, Doughty RN, Gardin JM, Hobbs FDR, McMurray JJV, Nagueh SF, Senior R, Thomas L, Whalley GA, Aune E, et al. Ethnic-specific normative reference values for echocardiographic LA and LV size, LV mass, and systolic function: the EchoNoRMAL study. JACC Cardiovasc Imaging. 2015;8:656–665. DOI: 10.1016/j.jcmg.2015.02.014
- Bozkurt B. Pre-heart failure: an important opportunity to prevent a deadly disease. JACC Heart Fail. 2023;11:1027–1031. DOI: 10.1016/j.jchf.2023.07.001
- Upadhya B, Hegde S, Tannu M, Stacey RB, Kalogeropoulos A, Schocken DD. Preventing new-onset heart failure: intervening at stage A. Am J Prev Cardiol. 2023;16:
100609 . DOI: 10.1016/j.ajpc.2023.100609 - Heidemann AI, Santos ABS, Bittencourt MS, Ribeiro ALP, Rohde LE, Lotufo PA, Duncan BB, Foppa M. Prevalence and mortality of heart failure stages in a free-living older adult population: data from the Brazilian Longitudinal Study of Adult Health. J Am Heart Assoc. 2025;14:
e038993 . DOI: 10.1161/JAHA.124.038993 - Taylor CJ, Beezer J, Fuat A, Halliday BP, Ludman AJ, Pellicori P, Savage HO, Cleland JGF. Predicting and preventing heart failure. Considerations Med. 2024;3:
e000007 . DOI: 10.1136/conmed-2024-000007 - White-Williams C, Rossi LP, Bittner VA, Driscoll A, Durant RW, Granger BB, Graven LJ, Kitko L, Newlin K, Shirey M; on behalf of the American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epidemiology and Prevention. Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association. Circulation. 2020;141:e841–e863. DOI: 10.1161/CIR.0000000000000767
- Potter EL, Hopper I, Sen J, Salim A, Marwick TH. Impact of socioeconomic status on incident heart failure and left ventricular dysfunction: systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2019;5:169–179. DOI: 10.1093/ehjqcco/qcy047
- Trends in cardiometabolic risk factors in the Americas between 1980 and 2014: a pooled analysis of population-based surveys. Lancet Glob Health. 2020;8:e123–e133. DOI: 10.1016/S2214-109X(19)30484-X
- Brant LCC, Miranda JJ, Carrillo-Larco RM, Flood D, Irazola V, Ribeiro ALP. Epidemiology of cardiometabolic health in Latin America and strategies to address disparities. Nat Rev Cardiol. 2024;21:849–864. DOI: 10.1038/s41569-024-01058-2
- Hammond MM, Everitt IK, Khan SS. New strategies and therapies for the prevention of heart failure in high-risk patients. Clin Cardiol. 2022;45(suppl 1):S13–S25. DOI: 10.1002/clc.23839
- Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, et al; on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613. DOI: 10.1161/CIRCULATIONAHA.109.192703
- Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G, et al; on behalf of the American Heart Association. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146:e18–e43. DOI: 10.1161/CIR.0000000000001078
- Petermann-Rocha F, Deo S, Celis-Morales C, Ho FK, Bahuguna P, McAllister D, Sattar N, Pell JP. An opportunity for prevention: associations between the Life’s Essential 8 score and cardiovascular incidence using prospective data from UK Biobank. Curr Probl Cardiol. 2023;48:
101540 . DOI: 10.1016/j.cpcardiol.2022.101540 - Fitchett D, Zinman B, Wanner C, Lachin JM, Hantel S, Salsali A, Johansen OE, Woerle HJ, Broedl UC, Inzucchi, SE; EMPA-REG OUTCOME® Trial Investigators. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. Eur Heart J. 2016;37:1526–1534. DOI: 10.1093/eurheartj/ehv728
- Filippatos G, Anker SD, Agarwal R, Ruilope LM, Rossing P, Bakris GL, Tasto C, Joseph A, Kolkhof P, Lage A, et al; FIGARO-DKD Investigators. Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial. Circulation. 2022;145:437–447. DOI: 10.1161/CIRCULATIONAHA.121.057983
- Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, et al; SELECT Trial Investigators. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389:2221–2232. DOI: 10.1056/NEJMoa2307563
- Yusuf S, Pitt B, Davis CE, Hood WB
Jr , Cohn JN; SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691. DOI: 10.1056/NEJM199209033271003 - Ledwidge M, Gallagher J, Conlon C, Tallon E, O’Connell E, Dawkins I, Watson C, O’Hanlon R, Bermingham M, Patle A, et al. Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA. 2013;310:66–74. DOI: 10.1001/jama.2013.7588
- Huelsmann M, Neuhold S, Resl M, Strunk G, Brath H, Francesconi C, Adlbrecht C, Prager R, Luger A, Pacher R, et al. PONTIAC (NT-proBNP Selected Prevention of Cardiac Events in a Population of Diabetic Patients Without a History of Cardiac Disease): a prospective randomized controlled trial. J Am Coll Cardiol. 2013;62:1365–1372. DOI: 10.1016/j.jacc.2013.05.069
- Khan MS, Shahid I, Anker SD, Fonarow GC, Fudim M, Hall ME, Hernandez A, Morris AA, Shafi T, Weir MR, et al. Albuminuria and heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81:270–282. DOI: 10.1016/j.jacc.2022.10.028
- deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494–2502. DOI: 10.1001/jama.2010.1708
- Attia ZI, Kapa S, Lopez-Jimenez F, McKie PM, Ladewig DJ, Satam G, Pellikka PA, Enriquez-Sarano M, Noseworthy PA, Munger TM, et al. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat Med. 2019;25:70–74. DOI: 10.1038/s41591-018-0240-2
- Sangha V, Nargesi AA, Dhingra LS, Khunte A, Mortazavi BJ, Ribeiro AH, Banina E, Adeola O, Garg N, Brandt CA, et al. Detection of left ventricular systolic dysfunction from electrocardiographic images. Circulation. 2023;148:765–777. DOI: 10.1161/CIRCULATIONAHA.122.062646
- Dhingra L, Aminorroaya A, Pedroso Camargos A, Sangha V, Brant L, Barreto S, Ribeiro AL, Krumholz H, Oikonomou E, Khera R. Multinational clinical and community-based validation of PRESENT-SHD, an ensemble deep learning approach for the detection of multiple structural heart disorders using electrocardiographic images. Circulation. 2024;150:
A4146190 . Abstract. DOI: 10.1161/circ.150.suppl_1.4146190 - Dhingra L, Aminorroaya A, Pedroso A, Khunte A, Sangha V, McIntyre D, Chow C, Asselbergs F, Brant LCC, Barreto S, et al. Artificial intelligence enabled prediction of heart failure risk from single-lead electrocardiograms. medRxiv. Preprint posted online December 21, 2024. DOI: 10.1101/2024.05.27.24307952
- Dewan P, Jackson A, Lam CSP, Pfeffer MA, Zannad F, Pitt B, Solomon SD, McMurray JJV. Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure. Eur J Heart Fail. 2020;22:898–901. DOI: 10.1002/ejhf.1776
- Lam CSP, Voors AA, Piotr P, McMurray JJV, Solomon SD. Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction. Eur Heart J. 2020;41:2353–2355. DOI: 10.1093/eurheartj/ehaa158
- Campbell RT, Petrie MC, McMurray JJV. Redefining heart failure phenotypes based on ejection fraction. Eur J Heart Fail. 2018;20:1634–1635. DOI: 10.1002/ejhf.1325
- Morsing AE, Gnesin F, Lyass A, Andersson C. What is a normal left ventricular ejection fraction in healthy adults? A meta-analysis of population-based echocardiographic studies. J Cardiovasc Imaging. 2026;34:
2 . DOI: 10.1186/s44348-025-00063-4 - Agarwal A, Tromp J, Almahmeed W, Angermann C, Chandramouli C, Cho H, Choi DJ, Damasceno A, Filippatos G, Fonarow GC, et al; Global Heart Failure Roundtable Group. Toward a universal definition of etiologies in heart failure: categorizing causes and advancing registry science. Circ Heart Fail. 2024;17:
e011095 . DOI: 10.1161/CIRCHEARTFAILURE.123.011095 - Banerjee A, Pasea L, Chung SC, Direk K, Asselbergs FW, Grobbee DE, Kotecha D, Anker SD, Dyszynski T, Tyl B, et al. A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential. Eur J Heart Fail. 2022;24:466–480. DOI: 10.1002/ejhf.2417
- Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93:841–842. DOI: 10.1161/01.CIR.93.5.841
- Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB; on behalf of the American Heart Association. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816. DOI: 10.1161/CIRCULATIONAHA.106.174287
- Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, et al; ESC Scientific Document Group. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44:3503–3626. DOI: 10.1093/eurheartj/ehad194
- Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013;62:2046–2072. DOI: 10.1016/j.jacc.2013.08.1644
- Sliwa K. Heart failure can affect everyone: the ESC Geoffrey Rose lecture. Eur Heart J. 2020;41:1298–1306. DOI: 10.1093/eurheartj/ehaa084
- Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, Murray CJ. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667–1678. DOI: 10.1161/CIRCULATIONAHA.114.008720
- Odone A, McKee C, McKee M. The impact of migration on cardiovascular diseases. Int J Cardiol. 2018;254:356–361. DOI: 10.1016/j.ijcard.2017.11.084
- Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation. 2008;118:2360–2367. DOI: 10.1161/CIRCULATIONAHA.108.786244
- Ojji D, Stewart S, Ajayi S, Manmak M, Sliwa K. A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases. Eur J Heart Fail. 2013;15:835–842. DOI: 10.1093/eurjhf/hft061
- Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A. Worldwide risk factors for heart failure: a systematic review and pooled analysis. Int J Cardiol. 2013;168:1186–1194. DOI: 10.1016/j.ijcard.2012.11.065
- Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, Younis A, Dai H. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28:1682–1690. DOI: 10.1093/eurjpc/zwaa147
- Tromp J, Ferreira JP, Janwanishstaporn S, Shah M, Greenberg B, Zannad F, Lam CSP. Heart failure around the world. Eur J Heart Fail. 2019;21:1187–1196. DOI: 10.1002/ejhf.1585
- Hudson JA, Sanga L, Jobe M, Etyang AO, McAllister D, Perel P, Shah AS, Ogola EN. Sub-Saharan Africa’s contribution to clinical trials in international acute coronary syndromes and heart failure guidelines. JACC Adv. 2024;3:
101383 . DOI: 10.1016/j.jacadv.2024.101383 - Hulot J-S, Ter Maaten JM, Bayes-Genis A, Halliday BP, Metra M, Moura B, Petrie MC, Savarese G, Senni M, Van Linhout S, et al. Heart failure improvement, remission, and recovery: a European Journal of Heart Failure expert consensus document. Eur J Heart Fail. DOI: 10.1002/ejhf.3732
- Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Lam CSP, Lund LH, Ponikowski P, Voors AA, Zannad F, Zieroth S, et al. Worsening heart failure: nomenclature, epidemiology, and future directions: JACC review topic of the week. J Am Coll Cardiol. 2023;81:413–424. DOI: 10.1016/j.jacc.2022.11.023
- Metra M, Tomasoni D, Adamo M, Bayes-Genis A, Filippatos G, Abdelhamid M, Adamopoulos S, Anker SD, Antohi L, Böhm M, et al. Worsening of chronic heart failure: definition, epidemiology, management and prevention: a clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023;25:776–791. DOI: 10.1002/ejhf.2874
- Pocock SJ, Ferreira JP, Packer M, Zannad F, Filippatos G, Kondo T, McMurray JJV, Solomon SD, Januzzi JL, Iwata T, et al. Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur J Heart Fail. 2022;24:1869–1878. DOI: 10.1002/ejhf.2607
- McDowell K, Campbell R, Simpson J, Cunningham JW, Desai AS, Jhund PS, Lefkowitz MP, Rouleau JL, Swedberg K, Zile MR, et al. Incremental prognostic value of biomarkers in PARADIGM-HF. Eur J Heart Fail. 2023;25:1406–1414. DOI: 10.1002/ejhf.2887
- Lindenfeld J, Costanzo MR, Zile MR, Ducharme A, Troughton R, Maisel A, Mehra MR, Paul S, Sears SF, Smart F, et al; GUIDE-HF, CHAMPION, and LAPTOP-HF Investigators. Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2024;83:682–694. DOI: 10.1016/j.jacc.2023.11.030
- Bozkurt B. Differentiation between worsening heart failure and decompensated heart failure. JACC Heart Fail. 2023;11:859–861. DOI: 10.1016/j.jchf.2023.06.001
- Bozkurt B. Proposed new conceptualization for definition of decompensated HF: taking the acute out of decompensation. JACC Heart Fail. 2023;11:368–371. DOI: 10.1016/j.jchf.2023.02.001
- Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction: Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med. 1995;333:1670–1676. DOI: 10.1056/NEJM199512213332503
- Vantrimpont P, Rouleau JL, Wun CC, Ciampi A, Klein M, Sussex B, Arnold JM, Moyé L, Pfeffer M. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study: SAVE Investigators. J Am Coll Cardiol. 1997;29:229–236. DOI: 10.1016/S0735-1097(96)00489-5
- Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C, Armstrong W, Good E, Chugh A, Jongnarangsin K, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7:865–869. DOI: 10.1016/j.hrthm.2010.03.036
- Penela D, Van Huls Van Taxis C, Van Huls Vans Taxis C, Aguinaga L, Fernández-Armenta J, Mont L, Castel MA, Heras M, Tolosana JM, Sitges M, et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol. 2013;62:1195–1202. DOI: 10.1016/j.jacc.2013.06.012
- Penela D, Acosta J, Aguinaga L, Tercedor L, Ordoñez A, Fernández-Armenta J, Andreu D, Sánchez-Millán PJ, Cabanelas N, Tolosana JM, et al. Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: safety of withholding the implant. Heart Rhythm. 2015;12:2434–2442. DOI: 10.1016/j.hrthm.2015.09.011
- Friday JM, Cleland JGF, Pellicori P, Wolters MK, McMurray JJV, Jhund PS, Forsyth P, McAllister DA, Graham FJ, Jones Y, et al. Loop diuretic therapy with or without heart failure: impact on prognosis. Eur Heart J. 2024;45:3837–3849. DOI: 10.1093/eurheartj/ehae345
- Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, et al; ESC Scientific Document Group. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415–3537. DOI: 10.1093/eurheartj/ehae177
DOI: https://doi.org/10.5334/gh.1569 | Journal eISSN: 2211-8179
Language: English
Page range: 51 - 51
Submitted on: Jun 11, 2026
Accepted on: Jun 11, 2026
Published on: Jun 29, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Keywords:
© 2026 Mary Norine Walsh, Lars Køber, Karen Hahnle-Sliwa, Marianna Adamo, Anubha Agarwal, Amitava Banerjee, Biykem Bozkurt, Maja Cikes, Albertino Damasceno, Akshay Desai, G. Michael Felker, Gail Hogan, Koichiro Kinugawa, Michelle Kittleson, Carolyn Lam, Theresa McDonagh, Marco Metra, Wilfried Mullens, Antonio Ribeiro, Yolanda Vaughn, Amanda Vest, the Heart Failure Association (HFA) of the European Society of Cardiology on behalf of the Joint American Heart Association (AHA)/American College of Cardiology (ACC)/European Society of Cardiology (ESC)/ World Heart Federation (WHF) Task Force for the Universal Definition of Heart Failure in collaboration with the Heart Failure Society of America (HFSA), published by Ubiquity Press
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.